GPCR Activation Monitoring Protocol
Corresponding Organization : University of Birmingham
Other organizations : Monash University, Harry Perkins Institute of Medical Research, University of Western Australia, Promega (United States), Salk Institute for Biological Studies, Peter MacCallum Cancer Centre, University of California, Los Angeles, Victorian Comprehensive Cancer Centre
Variable analysis
- VEGF165a
- VEGF165a-TMR
- BODIPY-CGP12177-TMR
- CGP12177
- ICI118551
- β-arrestin2-Venus-YFP
- Not explicitly mentioned
- All materials were purchased from Sigma-Aldrich (Gillingham, UK) unless otherwise stated
- FuGENE-HD, ONE-Glo™ luciferase and HaloTag® AF488 ligand were purchased from Promega Corporation (Wisconsin, USA)
- Opti-MEM was purchased from Thermo-Fisher Scientific (Massachusetts, USA)
- SNAP-Tag® AlexaFluor 647 (AF647) and AlexaFluor 488 (AF488) were purchased from New England BioLabs (Massachusetts, USA)
- VEGF165a
- CGP12177
- ICI118551
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!